Shell Asset Management Co. Acquires 10,647 Shares of Walgreens Boots Alliance Inc (WBA)

Shell Asset Management Co. grew its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 144,009 shares of the pharmacy operator’s stock after purchasing an additional 10,647 shares during the quarter. Shell Asset Management Co.’s holdings in Walgreens Boots Alliance were worth $10,498,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Asset Dedication LLC raised its position in shares of Walgreens Boots Alliance by 204.6% in the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after acquiring an additional 1,060 shares during the period. BlueMountain Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $103,000. CSat Investment Advisory L.P. acquired a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $104,000. Kaizen Advisory LLC raised its position in shares of Walgreens Boots Alliance by 128.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after acquiring an additional 1,083 shares during the period. Finally, Capital Advisors Ltd. LLC raised its position in shares of Walgreens Boots Alliance by 1,150.3% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock valued at $150,000 after acquiring an additional 1,898 shares during the period. 64.29% of the stock is currently owned by institutional investors.

In related news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction on Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total value of $4,096,040.00. Following the completion of the transaction, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total transaction of $217,457.28. Following the completion of the transaction, the director now directly owns 8,207 shares of the company’s stock, valued at $652,292.36. The disclosure for this sale can be found here. Insiders sold 73,756 shares of company stock worth $5,824,194 over the last quarter. 14.80% of the stock is owned by corporate insiders.

NASDAQ WBA opened at $80.81 on Monday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $83.18. The company has a market capitalization of $76.70 billion, a PE ratio of 13.42, a price-to-earnings-growth ratio of 1.26 and a beta of 0.74.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The company had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. On average, analysts predict that Walgreens Boots Alliance Inc will post 6.54 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.18%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.

Several analysts have commented on the stock. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 target price on the stock in a report on Saturday, October 13th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, August 28th. Robert W. Baird raised their target price on shares of Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a report on Friday, October 12th. Barclays raised their target price on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a report on Friday, October 12th. Finally, JPMorgan Chase & Co. raised their target price on shares of Walgreens Boots Alliance from $83.00 to $91.00 and gave the stock an “overweight” rating in a report on Monday, October 8th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $78.22.

ILLEGAL ACTIVITY WARNING: “Shell Asset Management Co. Acquires 10,647 Shares of Walgreens Boots Alliance Inc (WBA)” was first posted by WKRB News and is owned by of WKRB News. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.wkrb13.com/2018/11/26/shell-asset-management-co-acquires-10647-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: Stock Symbols Definition, Examples, Lookup

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply